Dihydromethysticin

Overview

Dihydromethysticin is an orally active natural active ingredient. Dihydromethysticin can be extracted from Piper methysticum . Dihydromethysticin inhibits carboxylesterase 1 ( K i = 68.2 μM) and CYP2A5 . Dihydromethysticin upregulates NLRC3 and induces Apoptosis . Dihydromethysticin exhibits anticancer activity against colorectal cancer and lung adenoma.

Application

Products | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Carboxylesterase (CES) | Products > Signaling Pathways > NOD-like Receptor (NLR) | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-N0921
• CAS No.: 19902-91-1
• Molecular Formula: C15H16O5
• Molecular Weight: 276.29
• Purity: 99.71%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.5 mg/mL (9.05 mM); Clear solution
• Availability: In-stock

Source

Original product source